Meeting Agenda

Saturday 11th September 2021

Saturday 18th September 2021

Time
Session
Speaker
10:00-10:05
Welcome back and agenda
Hanan Al-Rayes
Session 1a: Hot topics in rheumatic disease
Chair: Hanan Al Rayes
1b: Pediatric rheumatology
Chairs: Sulaiman Al-Mayouf and Mohammad Saud Altowijry
10:05
Treat-to-target and tapering strategies: What’s new?
Ernest Choy
10:05
Childhood vasculitis: Up to Date from EULAR 2021
Entesar Batouk
10:25
Biosimilars: Real-world data
Ernest Choy
10:45
Pfizer Symposia
Speaker: Kunihiro Yamaoka
Chair: Waleed Hussain
EULAR Recommendations for the management of 2 groups of Autoinflammatory diseases, IL-1-mediated and Type-I Interferonopathies, and for the early management of suspected Macrophage Activation Syndrome: Best of systemic autoinflammatory diseases from EULAR 2021
Sajdi AlMutairi
11:15
Q&A and Discussion
11:25
Break
10:35
Session 2: A focus on…….
Chair: Mohammed Al-Omair
11:30
Interstitial lung disease and pulmonary hypertension in rheumatic disease
Nabil Alhakami
11:50
Cardiovascular risks in rheumatic disease
Manal Hasan
11:05
Juvenile Idiopathic Arthritis: Best abstracts from EULAR 2021
Mada Yateem
12:10
Q&A and discussion
12:15
Break
11:35
Q&A and Discussion
Session 3: Spotlight on Lupus
Chair: Khawala Alghanem
12:25
Lupus nephritis: What’s new?
Thomas Dörner
12:45
Non-renal manifestations in SLE
Samar Alharbi
13:05
Q&A, discussion and close
Time
Session
Speaker
10:00
Welcome back and agenda
Fehaid Alanazi
Session 1: Hot topics in rheumatic disease continued
Chair: Fehaid Alanazi
10:05
New data in RA: Emerging therapies
Hussein Halabi
10:30
COVID-19 and rheumatic diseases
Ahmed Abdulshakour
10:50
Q&A and Discussion
10:55
Pfizer Symposia
Chair: Mohamed Bedaiwi
Bassel El-Zorkany
11:25
BREAK
Session 2: Spondyloarthritis (SpA) highlights
Chair: Mansour Alazmi
11:30
An update in diagnosis and treatment of axSpA – Status in 2021
Xenofon Baraliakos
11:50
Peripheral SpA
Bassel El-Zorkany
12:20
Q&A and Discussion
12:25
BREAK
Session 3: A focus on…
Chair: Suzan Attar
12:35
Inflammatory myopathies and Sjögren’s disease
Dennis McGonagle
12:55
Updates in managing non-ANCA associated vasculitis
Dennis McGonagle
13:15
Treatment of ANCA-associated vasculitis in 2021
Abdulrahman Alrashid
13:35
Q&A, discussion and close